Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 9, 2013 - Issue 2
Submit an article Journal homepage
2,410
Views
44
CrossRef citations to date
0
Altmetric
Commentary

mRNA

From a chemical blueprint for protein production to an off-the-shelf therapeutic

Sandra Van Lint Laboratory of Molecular and Cellular Therapy; Department of Immunology-Physiology; Medical School of the “Vrije Universiteit Brussel”; Jette, Belgium
,
Carlo Heirman Laboratory of Molecular and Cellular Therapy; Department of Immunology-Physiology; Medical School of the “Vrije Universiteit Brussel”; Jette, Belgium
,
Kris Thielemans Laboratory of Molecular and Cellular Therapy; Department of Immunology-Physiology; Medical School of the “Vrije Universiteit Brussel”; Jette, Belgium
&
Karine Breckpot Laboratory of Molecular and Cellular Therapy; Department of Immunology-Physiology; Medical School of the “Vrije Universiteit Brussel”; Jette, BelgiumCorrespondence[email protected]
Pages 265-274 | Received 17 Oct 2012, Accepted 25 Oct 2012, Published online: 04 Jan 2013

Citations (44)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (9)

Aranit Harizaj, Stefaan C. De Smedt, Ine Lentacker & Kevin Braeckmans. (2021) Physical transfection technologies for macrophages and dendritic cells in immunotherapy. Expert Opinion on Drug Delivery 18:2, pages 229-247.
Read now
Carlo Iavarone, Derek T. O’hagan, Dong Yu, Nicolas F. Delahaye & Jeffrey B. Ulmer. (2017) Mechanism of action of mRNA-based vaccines. Expert Review of Vaccines 16:9, pages 871-881.
Read now
Patrícia Pereira, Maria Barreira, João A. Queiroz, Francisco Veiga, Fani Sousa & Ana Figueiras. (2017) Smart micelleplexes as a new therapeutic approach for RNA delivery. Expert Opinion on Drug Delivery 14:3, pages 353-371.
Read now
Ying K. Tam, Thomas D. Madden & Michael J. Hope. (2016) Pieter Cullis’ quest for a lipid-based, fusogenic delivery system for nucleic acid therapeutics: success with siRNA so what about mRNA?. Journal of Drug Targeting 24:9, pages 774-779.
Read now
Drew Weissman. (2015) mRNA transcript therapy. Expert Review of Vaccines 14:2, pages 265-281.
Read now
Kenneth Lundstrom. (2015) RNA-based drugs and vaccines. Expert Review of Vaccines 14:2, pages 253-263.
Read now
Sandra Van Lint, Dries Renmans, Katrijn Broos, Heleen Dewitte, Ine Lentacker, Carlo Heirman, Karine Breckpot & Kris Thielemans. (2015) The ReNAissanCe of mRNA-based cancer therapy. Expert Review of Vaccines 14:2, pages 235-251.
Read now
Daphné Benteyn, Carlo Heirman, Aude Bonehill, Kris Thielemans & Karine Breckpot. (2015) mRNA-based dendritic cell vaccines. Expert Review of Vaccines 14:2, pages 161-176.
Read now
Raquel P Deering, Sushma Kommareddy, Jeffrey B Ulmer, Luis A Brito & Andrew J Geall. (2014) Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines. Expert Opinion on Drug Delivery 11:6, pages 885-899.
Read now

Articles from other publishers (35)

Kyu-Won Lee, Judy Wai Ping Yam & Xiaowen Mao. (2023) Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations. Cells 12:17, pages 2147.
Crossref
Antony Joseph. 2023. Water Worlds in the Solar System. Water Worlds in the Solar System 115 166 .
Michael Saag. (2022) Wonder of wonders, miracle of miracles: the unprecedented speed of COVID-19 science. Physiological Reviews 102:3, pages 1569-1577.
Crossref
Anne-Cathrine S. Vogt, Lukas Jörg, Byron Martina, Pascal S. Krenger, Xinyue Chang, Andris Zeltins, Monique Vogel, Mona O. Mohsen & Martin F. Bachmann. (2022) Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies. Frontiers in Immunology 13.
Crossref
Bruno Bouça, Marisa Roldão, Paula Bogalho, Luís Cerqueira & José Silva-Nunes. (2022) Central Diabetes Insipidus Following Immunization With BNT162b2 mRNA COVID-19 Vaccine: A Case Report. Frontiers in Endocrinology 13.
Crossref
Flordeluna Z. Mesina. (2022) Severe Relapsed Autoimmune Hemolytic Anemia after Booster with mRNA-1273 COVID-19 vaccine. Hematology, Transfusion and Cell Therapy.
Crossref
Joline Ingels, Laurenz De Cock, Rupert L. Mayer, Pam Devreker, Karin Weening, Kelly Heyns, Nele Lootens, Saskia De Smet, Marieke Brusseel, Stijn De Munter, Melissa Pille, Lore Billiet, Glenn Goetgeluk, Sarah Bonte, Hanne Jansen, Sandra Van Lint, Georges Leclercq, Tom Taghon, Björn Menten, Karim Vermaelen, Francis Impens & Bart Vandekerckhove. (2022) Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials. Cytotherapy 24:2, pages 213-222.
Crossref
Pratibha Anand & Vincent P. Stahel. (2021) The safety of Covid-19 mRNA vaccines: a review. Patient Safety in Surgery 15:1.
Crossref
Alborz Rahmani, Guglielmo Dini, Andrea Orsi, Laura Sticchi, Bianca Bruzzone, Alfredo Montecucco, Luca Pellegrini, Alessia Manca, Alexander Domnich, Angela Battistini, Bruno Kusznir Vitturi, Sonia Zacconi, Nicoletta Debarbieri, Giancarlo Icardi & Paolo Durando. (2021) Reactogenicity of BNT162b2 mRNA COVID-19 Vaccine in a Young Working Age Population: A Survey among Medical School Residents, within a Mass Vaccination Campaign, in a Regional Reference Teaching Hospital in Italy. Vaccines 9:11, pages 1269.
Crossref
Emily H. Pilkington, Estelle J.A. Suys, Natalie L. Trevaskis, Adam K. Wheatley, Danijela Zukancic, Azizah Algarni, Hareth Al-Wassiti, Thomas P. Davis, Colin W. Pouton, Stephen J. Kent & Nghia P. Truong. (2021) From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases. Acta Biomaterialia 131, pages 16-40.
Crossref
Lien Van Hoecke, Kenny Roose, Marlies Ballegeer, Zifu Zhong, Niek N. Sanders, Stefaan De Koker, Xavier Saelens & Sandra Van Lint. (2020) The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of Administration. Molecular Therapy - Nucleic Acids 22, pages 373-381.
Crossref
Yang-zhuo Gu, Xing Zhao & Xiang-rong Song. (2020) Ex vivo pulsed dendritic cell vaccination against cancer. Acta Pharmacologica Sinica 41:7, pages 959-969.
Crossref
Yannick Willemen, Maarten Versteven, Marc Peeters, Zwi N. Berneman & Evelien L. J. Smits. (2020) Ribonucleic Acid Engineering of Dendritic Cells for Therapeutic Vaccination: Ready ‘N Able to Improve Clinical Outcome?. Cancers 12:2, pages 299.
Crossref
Sezer Okay, Öznur Özge Özcan & Mesut Karahan. (2020) Nanoparticle-based delivery platforms for mRNA vaccine development. AIMS Biophysics 7:4, pages 323-338.
Crossref
Mohamad-Gabriel Alameh, Drew Weissman & Norbert Pardi. 2022. mRNA Vaccines. mRNA Vaccines 111 145 .
Wesley de Jong, Joeri Aerts, Sabine Allard, Christian Brander, Jozefien Buyze, Eric Florence, Eric van Gorp, Guido Vanham, Lorna Leal, Beatriz Mothe, Kris Thielemans, Montse Plana, Félipe Garcia & Rob Gruters. (2019) iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy. Trials 20:1.
Crossref
Louis De Scheerder, Anders Sparén, Gunilla A. Nilsson, Per-Ola Norrby & Eivor Örnskov. (2018) Designing flexible low-viscous sieving media for capillary electrophoresis analysis of ribonucleic acids. Journal of Chromatography A 1562, pages 108-114.
Crossref
Vimal K. Udhayakumar, Ans De Beuckelaer, Joanne McCaffrey, Cian M. McCrudden, Jonathan L. Kirschman, Daryll Vanover, Lien Van Hoecke, Kenny Roose, Kim Deswarte, Bruno G. De Geest, Stefan Lienenklaus, Philip J. Santangelo, Johan Grooten, Helen O. McCarthy & Stefaan De Koker. (2017) Arginine‐Rich Peptide‐Based mRNA Nanocomplexes Efficiently Instigate Cytotoxic T Cell Immunity Dependent on the Amphipathic Organization of the Peptide. Advanced Healthcare Materials 6:13, pages 1601412.
Crossref
Vito Longo, Antonio Gnoni, Andrea Casadei Gardini, Salvatore Pisconti, Antonella Licchetta, Mario Scartozzi, Riccardo Memeo, Vincenzo Ostilio Palmieri, Giuseppe Aprile, Daniele Santini, Patrizia Nardulli, Nicola Silvestris & Oronzo Brunetti. (2017) Immunotherapeutic approaches for hepatocellular carcinoma. Oncotarget 8:20, pages 33897-33910.
Crossref
Lukasz Bialkowski, Kevin Van der Jeught, Dries Renmans, Alexia van Weijnen, Carlo Heirman, Marleen Keyaerts, Karine Breckpot & Kris Thielemans. 2017. RNA Vaccines. RNA Vaccines 179 191 .
Thomas Kramps & Knut Elbers. 2017. RNA Vaccines. RNA Vaccines 1 11 .
Anand Ramanathan, G. Brett Robb & Siu-Hong Chan. (2016) mRNA capping: biological functions and applications. Nucleic Acids Research 44:16, pages 7511-7526.
Crossref
Maridi Aerts. (2016) Current status and perspectives of immune-based therapies for hepatocellular carcinoma. World Journal of Gastroenterology 22:1, pages 253.
Crossref
Katrijn Broos, Kevin Van der Jeught, Janik Puttemans, Cleo Goyvaerts, Carlo Heirman, Heleen Dewitte, Rein Verbeke, Ine Lentacker, Kris Thielemans & Karine Breckpot. (2016) Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I Interferon. Molecular Therapy - Nucleic Acids 5, pages e326.
Crossref
Yu Fu & Jinming Li. (2016) A novel delivery platform based on Bacteriophage MS2 virus-like particles. Virus Research 211, pages 9-16.
Crossref
Sebastian Kreiter, Mustafa Diken, Abderraouf Selmi, Jutta Petschenka, Özlem Türeci & Ugur Sahin. 2016. Synthetic mRNA. Synthetic mRNA 163 175 .
Heleen Dewitte, Rein Verbeke, Karine Breckpot, Roosmarijn E. Vandenbroucke, Claude Libert, Stefaan C. De Smedt & Ine Lentacker. (2014) Choose your models wisely: How different murine bone marrow-derived dendritic cell protocols influence the success of nanoparticulate vaccines in vitro. Journal of Controlled Release 195, pages 138-146.
Crossref
Heleen Dewitte, Sandra Van Lint, Carlo Heirman, Kris Thielemans, Stefaan C. De Smedt, Karine Breckpot & Ine Lentacker. (2014) The potential of antigen and TriMix sonoporation using mRNA-loaded microbubbles for ultrasound-triggered cancer immunotherapy. Journal of Controlled Release 194, pages 28-36.
Crossref
Ugur Sahin, Katalin Karikó & Özlem Türeci. (2014) mRNA-based therapeutics — developing a new class of drugs. Nature Reviews Drug Discovery 13:10, pages 759-780.
Crossref
Laura Wayteck, Karine Breckpot, Jo Demeester, Stefaan C. De Smedt & Koen Raemdonck. (2014) A personalized view on cancer immunotherapy. Cancer Letters 352:1, pages 113-125.
Crossref
Sandra Van Lint, Sofie Wilgenhof, Carlo Heirman, Jurgen Corthals, Karine Breckpot, Aude Bonehill, Bart Neyns & Kris Thielemans. (2014) Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula. Cancer Immunology, Immunotherapy 63:9, pages 959-967.
Crossref
Kyle K. L. Phua, Herman F. Staats, Kam W. Leong & Smita K. Nair. (2014) Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity. Scientific Reports 4:1.
Crossref
Yuan Lin, Sherven Sharma & Maie John. (2014) CCL21 Cancer Immunotherapy. Cancers 6:2, pages 1098-1110.
Crossref
Karl-Josef Kallen & Andreas Theß. (2013) A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs. Therapeutic Advances in Vaccines 2:1, pages 10-31.
Crossref
S. Kreiter, M. Diken & U. Sahin. 2014. Cancer Immunotherapy Meets Oncology. Cancer Immunotherapy Meets Oncology 89 100 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.